(IN BRIEF) The Institute of Cancer Research, London, has announced the launch of the £42 million TRANSFORM trial, the UK’s largest prostate cancer screening study in more than 20 years. The first men have now been invited by their GPs … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged 42 million research investment, Black men prostate cancer risk, cancer genetics, Caroline Moore, clinical research, Ealing Community Diagnostic Centre, early diagnosis, fast MRI, genetic saliva test, Hashim Ahmed, Institute of Cancer Research, Institute of Cancer Research Supports Major UK Study Testing Advanced Screening Methods for Prostate Cancer, Lucy Chappell, Mark Emberton, men's health, NHS screening programme, NIHR, prostate cancer screening, Prostate Cancer UK, PSA testing, Rakesh Heer, Rhian Gabe, Ros Eeles, screening inequalities, TRANSFORM trial, UK National Screening Committee, Wes Streeting
(IN BRIEF) The largest study to date on testicular germ cell tumours (TGCTs) has revealed a potential link between testicular cancer risk and rare genetic variants affecting cellular movement and structure. Conducted by The Institute of Cancer Research, London, the … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer genetics, cell movement genes, Clare Turnbull, DNA mutations, European Urology Open Science, genetic risk, heritability in cancer, Movember Foundation, personalised medicine, rare genetic variants, testicular cancer, testicular germ cell tumours, TGCT, The Institute of Cancer Research, translational genomics, UK Biobank, whole-exome sequencing, Zeid Kuzbari
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?